Showing results (1-10 of 31) with videos related to
Sort By:
Pageof 4
Cancer Management and Research|June 1, 2011
Interpreting clinical assays for histone deacetylase inhibitorsNadine Martinet, Philippe BertrandDrug Discovery Today|April 1, 2014
Delivery of epidrugsFatima el Bahhaj, Frank J Dekker, Nadine Martinet, et al.Journal of Cellular and Molecular Medicine|March 28, 2008
Epigenetic effects of lung cancer predisposing factors impact on clinical diagnosis and prognosisChristina Piperi, Fotis Vlastos, Elena Farmaki, et al.Journal of Biomolecular Techniques : JBT|February 3, 2009
DNA methylation signature analysis: how easy is it to perform?Christina Piperi, Elena Farmaki, Fotis Vlastos, et al.Respiratory Medicine|December 17, 2005
Smoking cessation--but not smoking reduction--improves the annual decline in FEV1 in occupationally exposed workersAbraham B Bohadana, Fredrik Nilsson, Ake Westin, et al.Cell Cycle (Georgetown, Tex.)|December 22, 2009
An adult tissue-specific stem cell molecular phenotype is activated in epithelial cancer stem cells and correlated to patient outcomeThomas Hussenet, Doulaye Dembélé, Nadine Martinet, et al.Lung Cancer (Amsterdam, Netherlands)|April 7, 2009
Vitamin A/retinoids signalling in the human lungStéphane Poulain, Fanny Evenou, Marie-Christiane Carré, et al.Biochemistry and Cell Biology = Biochimie Et Biologie Cellulaire|April 5, 2014
Cell differentiation along multiple pathways accompanied by changes in histone acetylation statusSoňa Legartová, Stanislav Kozubek, Michal Franek, et al.Breast Cancer Research : BCR|November 21, 2014
Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancerFahimeh Falahi, Michel van Kruchten, Nadine Martinet, et al.The Journal of Laboratory and Clinical Medicine|November 16, 2002
Tumor infiltrating lymphocytes and macrophages have a potential dual role in lung cancer by supporting both host-defense and tumor progressionAgapi Kataki, Philippe Scheid, Maud Piet, et al.Pageof 4